Business News Today | 2 Min News | The Daily News Now!

Agios Pharmaceuticals’ stock soared nearly 14% after the FDA granted priority review to its sickle cell drug mitapivat — a potential first oral treatment to boost red blood cells and slash painful crises. Though earlier trials fell short on pain reduction, new patient-reported data revealed strong secondary benefits like less fatigue and fewer pain events, swaying the FDA. Full approval still hing...

Salesforce’s stock plummeted 40% in early 2026 as agentic AI reshaped the software landscape, triggering investor panic—even though finances held up. To counter, they launched a bold acquisition spree, buying data, pricing, and AI-driven customer service firms, while CEO Marc Benioff doubled down on AI as opportunity, not threat—with a $25B share buyback that boosted debt. Still, the stock trades...

Three under-the-radar stocks—Fortive, Stanley Black & Decker, and Renasant—are quietly struggling. Fortive’s sales are declining and earnings flat, Stanley’s tools face weak demand with falling profits, and Renasant’s revenue growth outpaces earnings, signaling shrinking profitability. While not dead picks, the data warns of serious headwinds—investors should dig deeper before diving in. Listen in...

Want higher income or maximum safety? Vanguard’s VCIT and VGIT ETFs let you choose. VCIT, focused on corporate bonds, delivers a juicy 4.8% yield and a 4.5% one-year return—perfect for those willing to take a bit more risk. VGIT, backed by U.S. Treasuries, offers safer, steadier returns at 3.8% yield and 2.4% return, ideal for conservative investors. Both have the same low expense ratio and are di...

Oil demand is set to drop for the first time since 2020, driven by Middle East turmoil, but recovery may be on the horizon—thanks to easing Strait of Hormuz tensions and a projected rebound by 2027. Yet, renewed U.S.-Iran clashes are threatening stability, risking supply disruptions and potentially leaving the market with a surplus. Peace remains the key to restoring normalcy. Listen in comfort: G...

Global oil demand could shrink for the first time since 2020, according to the IEA, as tensions in the Strait of Hormuz disrupt supply chains—especially for Asia’s import-dependent economies. Despite a recent four-million-barrel-per-day supply surge due to partial Strait reopenings, production remains far below pre-conflict levels. With the U.S. revoking Iranian oil exports and Iran retaliating wi...

Household staff are getting paid like rockstars—private chefs earn up to $300K, butlers hit $180K—as ultra-rich clients demand more complex, global lifestyles. A fierce talent war is driving record hiring and sky-high wages, with nannies, assistants, and estate managers commanding premium pay for multilingual skills, tech savvy, and absolute discretion. With clients jetting around the world and st...

Bank of America sees a $10 trillion global nuclear renaissance fueled by AI’s hunger for power, positioning small modular reactor pioneer NuScale as a high-risk, high-reward play — with shares at $9 now potentially soaring to $100 by 2030, valuing the company at $34 billion, if it can overcome execution hurdles and prove its tech at scale. Listen in comfort: Get a discount on a Soli Pillow: http:/...

NextEra Energy is poised to shock the energy world with a $67 billion bid to acquire Dominion Energy, creating the globe’s largest regulated utility and positioning itself as the ultimate power play for the AI boom. By merging Florida’s renewable giant with Dominion’s Southeast grid, NextEra aims to stabilize revenue while tapping into Virginia’s data center hub — a critical energy lifeline for AI...

Stocks under fifty dollars may seem tempting, but beware—some are teetering on shaky ground. MarineMax’s sales and earnings are plummeting, Provident Financial’s margins are weak and asset value is declining, and DHT Holdings has flat sales for five years with razor-thin profits. These aren’t just cheap—they’re risky. Stronger fundamentals, even at a higher price, often offer safer long-term retur...

Shein’s long-awaited Hong Kong IPO finally clears China’s approval hurdle after a year-long wait, amid geopolitical tensions and falling valuations—from $100B peak to rumored $40–50B. Once blocked from U.S. and London markets, the fast-fashion giant now faces scrutiny over labor practices and environmental impact, while its listing could boost Hong Kong’s booming IPO scene. Listen in comfort: Get...

SK Hynix just shattered records with the largest U.S. IPO ever by a foreign company, raising $26.5 billion via Nasdaq ADRs—topping even Alibaba’s 2014 debut. Priced at $149 per ADR, the offering drew seven times the demand, with proceeds fueling AI chip expansion in Korea and buying cutting-edge EUV machines. Dominating the HBM market with over 56% share and powering Nvidia’s AI ambitions, this li...

Delta Air Lines surprises investors with a strong Q2 2026 earnings beat—$1.56 EPS on $17.7B revenue—despite paying record fuel prices. CEO Ed Bastian credits resilient demand, brand loyalty, and premium seating (which outperformed economy) for the win. Fuel costs soared 75% to $3.93/gallon, but Delta covered 60% of the hike via higher fares. Net income dipped 25% due to fuel, but the airline reaff...

Fast-food titans Arcos Dorados and Domino’s face starkly different paths: Arcos Dorados, McDonald’s biggest Latin American franchisee, is upgrading stores to lure younger customers, posting $4.7B in revenue and $212M net income, but struggles with debt and regional economic volatility. Domino’s, the delivery king with 22,000 global stores, raked in $4.9B in revenue and $601M net income, boasting a...

Healthcare’s on fire—outpacing the S&P 500 with innovation and returns, but don’t get too comfy: regulation can hit hard. Biogen’s slipping, sales and margins crumbling under rising competition. UFP Technologies? Solid tech, but tiny scale means little leverage. Enter Pfizer—massive revenue, razor-sharp efficiency, and serious negotiating power. The takeaway? Pick your battles: Pfizer’s a winner,...

The stock market’s soaring on AI-driven momentum, but beneath the surface, inflation fears are mounting — with the Fed now pointing to AI infrastructure demand as a key culprit. Rising energy costs tied to the Iran situation and lingering tariff effects are also pushing prices up. If the Fed responds by hiking rates to curb this AI-fueled inflation, it could cool the tech rally and force investors...

Looking for stocks with real staying power? Forget overhyped growth plays—experts are spotlighting Broadcom, MercadoLibre, and Micron. Broadcom, a semiconductor titan worth nearly $2 trillion, is crushing it with 36% annual gains for 15 years, AI chip sales up 143%, and a surprisingly fair valuation. MercadoLibre, Latin America’s Amazon, averages 29% annual growth, rides a booming e-commerce wave,...

SpaceX’s record-breaking IPO has sent shockwaves through Wall Street, sparking wild speculation about its impact on Tesla—and Elon Musk’s entire empire. Trading around $152 after a volatile debut, SpaceX’s $2 trillion market cap dwarfs Tesla’s $1.5 trillion, even though it’s still bleeding billions in losses. Analysts are bullish, calling it a historic leap for humanity’s future in space, but crit...

SK Hynix’s historic Nasdaq debut—raising $26B, the largest foreign IPO ever in the U.S.—is the market’s biggest story today, testing AI sector momentum as chip stocks dip ahead of the listing. Meanwhile, oil prices climb on Middle East tensions, with WTI near $72 and Brent over $76, while Delta Air Lines’ stock falls despite beating earnings due to soaring fuel costs. Markets remain mixed, with Do...

Fidji Simo, OpenAI’s former product and business lead, is stepping down from full-time duties due to worsening POTS symptoms since 2019, now taking on a part-time advisory role. Her departure, timed with OpenAI’s IPO prep, creates a major leadership vacuum as her responsibilities are split among Greg Brockman, CFO Sarah Friar, and Jason Kwon. Simo, who once turned down a medical leave offer she no...

Restaurant stocks are under pressure, down 3% while the S&P 500 climbs—hinting at tighter wallets and more home cooking. But not all are sinking: Wingstop’s sales surge and strong cash flow make it a standout, while Brinker International (Chili’s, Maggiano’s) shows smart growth and efficiency. Meanwhile, Wendy’s lags with sluggish sales, mounting debt, and flat revenue forecasts—Wall Street’s warn...

SK Hynix is making waves on Wall Street with its record-breaking $26.5 billion U.S. IPO, the largest ever by a foreign company, as demand for AI chips surges. The South Korean giant, partnering with Nvidia, is at the heart of the AI boom, driving chip prices higher and forcing tech giants like Apple to raise device costs. With a $518 billion national investment to expand chipmaking beyond Seoul, S...

Want to invest in healthcare? Two top ETFs to consider: IHE for steady income from big pharma giants like Johnson & Johnson, and IBB for high-growth exposure to biotech innovators. IHE offers lower costs, higher dividends, and less volatility—ideal for retirees or income seekers. IBB delivers explosive growth potential but comes with higher risk and lower yields—perfect for long-term investors cha...

The FTSE 100 edged higher Friday fueled by big deals—Vodafone surged after a $6B UAE stake sale to a French billionaire, and easyJet jumped on a $7.5B takeover bid—yet global tensions, including U.S. military strikes in the Gulf, kept investors cautious. Industrial miners like Rio Tinto and recruiter Hays posted gains, showing sector resilience, but the market remains caught between deal-driven op...

Looking for steady income with long-term investing? Three top dividend ETFs deliver diversified, low-risk exposure: Schwab’s SCHD (98B assets, 0.06% fee) targets reliable U.S. dividend payers like UnitedHealth; SPDR’s SDY (22B assets, 0.35% fee) focuses on 20+ year dividend growers including Realty Income; and iShares’ DGRO (39B assets, 0.08% fee) hunts for dividend growth potential with giants li...